ATE237352T1 - Helfervirus-freie herstellung von aav - Google Patents

Helfervirus-freie herstellung von aav

Info

Publication number
ATE237352T1
ATE237352T1 AT96918295T AT96918295T ATE237352T1 AT E237352 T1 ATE237352 T1 AT E237352T1 AT 96918295 T AT96918295 T AT 96918295T AT 96918295 T AT96918295 T AT 96918295T AT E237352 T1 ATE237352 T1 AT E237352T1
Authority
AT
Austria
Prior art keywords
helper virus
aav
free production
virus
production
Prior art date
Application number
AT96918295T
Other languages
English (en)
Inventor
Forrest K Ferrari
Xiao Xiao
Richard J Samulski
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE237352T1 publication Critical patent/ATE237352T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96918295T 1995-06-07 1996-06-06 Helfervirus-freie herstellung von aav ATE237352T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48375795A 1995-06-07 1995-06-07
PCT/US1996/009405 WO1996040240A1 (en) 1995-06-07 1996-06-06 Helper virus-free aav production

Publications (1)

Publication Number Publication Date
ATE237352T1 true ATE237352T1 (de) 2003-05-15

Family

ID=23921407

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918295T ATE237352T1 (de) 1995-06-07 1996-06-06 Helfervirus-freie herstellung von aav

Country Status (7)

Country Link
EP (1) EP0871483B1 (de)
JP (1) JP4108746B2 (de)
AT (1) ATE237352T1 (de)
AU (1) AU707862B2 (de)
CA (1) CA2221293C (de)
DE (1) DE69627532T2 (de)
WO (1) WO1996040240A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2317646T3 (es) * 1995-09-08 2009-04-16 Genzyme Corporation Vectores aav mejorados para terapia genica.
US6004797A (en) 1995-11-09 1999-12-21 Avigen, Inc. Adenovirus helper-free recombinant AAV Virion production
US6221646B1 (en) 1997-07-31 2001-04-24 Chiron Corporation Materials and methods for simplified AAV production
CA2303768C (en) * 1997-09-19 2009-11-24 The Trustees Of The University Of Pennsylvania Methods and vector constructs useful for production of recombinant aav
PT1064393E (pt) * 1998-03-20 2005-04-29 Univ Pennsylvania Composicoes e metodos para a producao de virus adeno-associados recombinantes sem auxiliar
US6953690B1 (en) 1998-03-20 2005-10-11 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
AU764130B2 (en) * 1998-10-27 2003-08-14 Crucell Holland B.V. Improved AAV vector production
JP4693244B2 (ja) 1999-03-18 2011-06-01 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
US6258595B1 (en) 1999-03-18 2001-07-10 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
WO2001083797A2 (en) 2000-04-28 2001-11-08 Avigen, Inc. Polynucleotides for use in recombinant adeno-associated virus virion production
SG10201702685WA (en) 2012-10-03 2017-04-27 Glaxosmithkline Biolog Sa Immunogenic composition
JP6767483B2 (ja) 2015-11-05 2020-10-14 バンブー セラペウティクス インク 遺伝子療法のための、改変されたフリードライヒ運動失調症遺伝子およびベクター
CA2971303A1 (en) 2016-06-21 2017-12-21 Bamboo Therapeutics, Inc. Optimized mini-dystrophin genes and expression cassettes and their use
US20230241248A1 (en) 2019-06-27 2023-08-03 Pfizer Inc. Methods of treating duchenne muscular dystrophy using aav mini-dystrophin gene therapy
US20230399656A1 (en) 2020-11-03 2023-12-14 Pfizer Inc. Methods for Purification of AAV Vectors by Anion Exchange Chromatography
WO2022137076A1 (en) 2020-12-23 2022-06-30 Pfizer Inc. Methods for purification of aav vectors by affinity chromatography
US11760788B2 (en) 2021-03-02 2023-09-19 Pathways Neuro Pharma, Inc. Neuroreceptor compositions and methods of use
CN117377500A (zh) 2021-04-26 2024-01-09 阿雷克森国际制药有限公司 具有改善的组织向性的腺相关病毒载体衣壳
CN113308492B (zh) * 2021-05-31 2023-03-21 北京中因科技有限公司 一种用于复制性aav的检测方法
WO2023114816A1 (en) 2021-12-14 2023-06-22 Neurogene, Inc. Recombinant optimized galc constructs and methods for treating galc-associated disorders
GB202201242D0 (en) 2022-01-31 2022-03-16 Univ Edinburgh Recombinant optimized mecp2 cassettes and methods for treating rett syndrome and related disorders
GB202206336D0 (en) 2022-04-29 2022-06-15 Univ Edinburgh Recombinant therapeutic FMR1 constructs and methods of treating fragile X syndrome and related disorders
WO2024003687A1 (en) 2022-06-28 2024-01-04 Pfizer Inc. Nucleic acids encoding acid alpha-glucosidase (gaa) and vectors for gene therapy
WO2024038365A1 (en) 2022-08-16 2024-02-22 Pfizer Inc. Methods for purification of aav vectors by anion exchange chromatography

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436146A (en) * 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
EP0689601B1 (de) * 1993-02-22 2006-10-04 The Rockefeller University Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion

Also Published As

Publication number Publication date
EP0871483A4 (de) 2000-01-05
DE69627532D1 (de) 2003-05-22
AU707862B2 (en) 1999-07-22
EP0871483A1 (de) 1998-10-21
WO1996040240A1 (en) 1996-12-19
CA2221293A1 (en) 1996-12-19
CA2221293C (en) 2012-09-18
AU6098596A (en) 1996-12-30
JP4108746B2 (ja) 2008-06-25
JPH11510371A (ja) 1999-09-14
EP0871483B1 (de) 2003-04-16
DE69627532T2 (de) 2004-01-29

Similar Documents

Publication Publication Date Title
ATE237352T1 (de) Helfervirus-freie herstellung von aav
ATE91714T1 (de) Transformation von trichoderma.
ATE328068T1 (de) Papillomavirus vakzine
GR880100248A (el) Ουσιες για την προφυλαξη και θεραπεια ρετροιογενην φλεγμωνων.
DE69332626D1 (de) Herstellung von Brillenlinsen
DE3678151D1 (de) Dispersionen von fasern in kautschuk.
ES2035920T3 (es) Aerolizacion de agente proteico terapeutico.
FI951138A (fi) Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
FI904827A0 (fi) Kalciumkanalsammansaettningar och -foerfaranden.
DE3788984D1 (de) Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom.
DE69001551D1 (de) Latexfilme von naturkautschuk von modifizierter zugfestigkeit.
ATE112317T1 (de) Bcrf1-proteine als inhibitoren von interferon- g(g).
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
HUP0001184A2 (hu) "Basic Helix-Loop-Helix" (bHLH) családba tartozó polipeptidek és a megfelelő nukleinsav-szekvenciák
ATE149344T1 (de) Verwendung von hydroxynaphthalinen in färbemitteln
DE3689175D1 (de) Rekombinante Wirte, deren Herstellung und Verwendung.
SU888095A1 (ru) Регулируемый источник посто нного тока
DE69400223D1 (de) Verwendung von Textilbehandlungszusammensetzungen
DE3881953D1 (de) Expression von fremden genen in drosophila-zellen.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
DE69011565D1 (de) Herstellung von Pre-Kaseinaten und Verwendung.
DE69307083D1 (de) Verbesserungen in/oder bezüglich der Herstellung von ophtalmischen Linsen
ES2070210T3 (es) Derivado del activador de plasminogeno de tejido.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties